Roles of trans-lesion synthesis (TLS) DNA polymerases in tumorigenesis and cancer therapy.
Ontology highlight
ABSTRACT: DNA damage tolerance and mutagenesis are hallmarks and enabling characteristics of neoplastic cells that drive tumorigenesis and allow cancer cells to resist therapy. The 'Y-family' trans-lesion synthesis (TLS) DNA polymerases enable cells to replicate damaged genomes, thereby conferring DNA damage tolerance. Moreover, Y-family DNA polymerases are inherently error-prone and cause mutations. Therefore, TLS DNA polymerases are potential mediators of important tumorigenic phenotypes. The skin cancer-propensity syndrome xeroderma pigmentosum-variant (XPV) results from defects in the Y-family DNA Polymerase Pol eta (Polη) and compensatory deployment of alternative inappropriate DNA polymerases. However, the extent to which dysregulated TLS contributes to the underlying etiology of other
SUBMITTER: Anand J
PROVIDER: S-EPMC9900426 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA